Press Releases

NORTH READING, Mass., Oct. 24, 2019 /PRNewswire/ -- TraceLink Inc., the world's largest integrated digital supply network providing real-time information sharing for better patient ou

WASHINGTON, Oct. 24, 2019 /PRNewswire/ -- After a lengthy national search, Unity Health Care (Unity) is pleased to announce the hiring of Jessica Henderson Boyd, MD, as its new Chief Medical Officer (CMO) effective November 18, 2019. Dr. Boyd comes to Unity with a wealth of leadership experience in the delivery

SOUTH PLAINFIELD, N.J., Oct. 24, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced new results from its investigational gene therapy, PTC-AADC, in patients living with aromatic L-amino acid decarboxylase (AADC) deficiency. The data demonstrated clinically meaningful and sustained improvements in motor, cognitive and language milestones.

WALTHAM, Mass., Oct. 24, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announced today

CRANFORD, N.J., Oct. 24, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing adjunctive cancer care and critical care drug products, announced today that the Company will present at the 5th Annual Dawson James Small Cap Growth Conference on

HARTFORD, Conn., Oct. 24, 2019 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), announced its 2020 Medicare offerings, featuring expanded plan options with low or $0 monthly premiums in most areas, plus enhanced benefits that focus on members' total health.

PORTLAND, Ore., Oct. 24, 2019 /PRNewswire/ -- Hemp-derived CBD wellness company Social CBD (www.thesocialcbd.com) introduces Social CBD PETS Broad Spectrum Drops. On

DULUTH, Ga., Oct. 24, 2019 /PRNewswire/ -- Sebacia, Inc., a privately held, commercial stage dermatology and aesthetics company, today announced that new long-term, real-world data from two studies evaluating the Company's proprietary Sebacia Microparticles will be featured in two separate oral presentations during the American Society for Dermatologic Surgery (ASDS

SALT LAKE CITY, Oct. 24, 2019 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, today announced the presentation of new preclinical neuroprotection data in multiple Parkinson's disease models at the 2019 Society for Neuroscience (SfN) Annual Meeting. Clene's Head of Translational Medicine, Dr. Karen

WEST PALM BEACH, Fla., Oct. 24, 2019 /PRNewswire/ -- Online Travel Training (OTT) and the Medical Tourism Association (MTA) have signed an agreement for phase two partnership with a goal to educate and engage travel agents in the UK in medical tourism.